Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test

American Journal of Gastroenterology

Volumn 100, Issue 11, 2005, Pages 2519-2525

  Vilkin, Alex ^a   Rozen, Paul ^a,b,d   Levi, Zohar ^a   Waked, Amal ^a   Maoz, Eran ^c   Birkenfeld, Shlomo ^c   Niv, Yaron ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC; HEMOGLOBIN;

ADULT; AGED; APPARATUS; ARTICLE; COLORECTAL CANCER; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EVALUATION; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOCHEMISTRY; LABORATORY AUTOMATION; LOW TEMPERATURE; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; OCCULT BLOOD TEST; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE ASSAY; REPRODUCIBILITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; ADENOMA; CHEMISTRY; COLON POLYP; COLON TUMOR; COLONOSCOPY; DECISION MAKING; FECES; INTESTINE POLYP; MASS SCREENING; METHODOLOGY; MIDDLE AGED; OBSERVER VARIATION; RECTUM TUMOR; RISK FACTOR; STANDARD; TIME; VILLOUS ADENOMA;

ADENOMA; ADENOMA, VILLOUS; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; DECISION MAKING; FECES; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOCHEMISTRY; INTESTINAL POLYPS; MALE; MASS SCREENING; MIDDLE AGED; OBSERVER VARIATION; OCCULT BLOOD; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33644636467     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.00231.x     Document Type: Article

References (23)

1. Young GP St. John DJ Winawer SJ, et al. Choice of fecal occult blood tests for screening: Recommendations based on performance characteristics in population studies: A WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002 97 : 2499 507.
2. Niv Y. Fecal occult blood test - The importance of proper processing. J Clin Gastroenterol 1990 12 : 393 5.
3. Young GP Rozen P Levin B. How should we screen for early colorectal neoplasia. In : Rozen P Young GP Levin B Spann SJ, eds. Colorectal cancer in clinical practice. London : Martin Dunitz, 2002 77 99.
4. Selinger RR Nolman S Dominitz JA. Failure of health care professionals to interpret fecal occult blood tests accurately. Am J Med 2003 114 : 64 7.
5. Allison JE Tekawa IS Ransom LJ, et al. A comparison of fecal-occult blood tests for colorectal-cancer screening. N Engl J Med 1996 336 : 155 9.
6. Rozen P Knaani J Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci 1997 42 : 2064 71.
7. Saito H Soma Y Nakajima M, et al. A case-control study evaluating occult blood screening with hemoccult test and an immunochemical hemagglutination test. Oncol Rep 2000 7 : 815 9.
8. Rozen P Knaani J Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test within an endoscopy study. Cancer 2000 89 : 46 52.
9. Young GP St John DJB Cole SR. Prescreening evaluation of a brush-based faecal immunochemical test for haemoglobin. J Med Screen 2003 10 : 123 8.
10. Wong BCY Wong WM Cheung KL, et al. A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population. Aliment Pharmacol Ther 2003 18 : 941 6.
11. Young GP. Fecal immunochemical tests (FIT) vs. office-based guaiac fecal occult blood test (FOBT). Pract Gastroenterol 2004 3 : 46 56 ( http://www.practicalgastro.com).
12. Castiglione G Grazzini G Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002 9 : 99 103.
13. Saito H Yoshida Y. Mass screening: Japanese perspective. In: Young GP Rozen P Levin B, eds. Prevention and early detection of colorectal cancer. London : WB Saunders, 1996 : 301 12.
14. Rozen P Knaani J Samuel Z. Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test. Dig Dis Sci 1999 44 : 756 60.
15. Nakama H Kamijo N Miyata K, et al. Sensitivity and specificity of several immunochemical tests for colorectal cancer. Hepato-Gastroenterol 1998 45 : 1579 82.
16. Nakama H Yamamoto M Kamijo N, et al. Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia. Hepato-Gastroenterol 1999 46 : 228 31.
17. Castiglione G Zappa M Grazzini G, et al. Screening for colorectal cancer by faecal occult blood test: Comparison of immunochemical tests. J Med Screen 2000 7 : 35 7.
18. Grazzini G Castiglione G Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: First round results. Eur J Cancer Prev 2004 13 : 19 26.
19. Crotta S Castiglione G Grazzini G, et al. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: Results in a northern Italian community. Eur J Gastroenterol Hepatol 2004 16 : 33 7.
20. Nakama H Zhang B Fattah ASMA. A cost-effective analysis of the optimum number of stool specimens collected for immunochemical occult blood screening for colorectal cancer. Eur J Cancer 2000 36 : 647 50.
21. Nakama H Zhang B Zhang Y. Evaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer 2001 37 : 398 401.
22. Bampton PA Sandford JJ Cole SR, et al. Interval faecal occult blood testing in a colonoscopy based screening programme detects additional pathology. Gut 2005 54 : 803 6.
23. Wong WM Lam SK Cheung KL, et al. Evaluation of an automated immunochemical faecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer 2003 97 : 2420 4.